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pLong-term Results With the Talent Thoracic Stent Graft in the
VALOR Trial
Paul J. Foley, MD, Frank J. Criado, MD, Mark A. Farber, MD, Christopher
J. Kwolek, MD, Manish Mehta, MD, Rodney A. White, MD, Ronald M.
Fairman, MD, University of Pennsylvania, Philadelphia, Pa
Objective(s): This report evaluates the 5-year outcomes of thoracic
endovascular aneurysm repair (TEVAR) using the Medtronic Vascular Tal-
ent Thoracic Stent Graft System (Medtronic Vascular, Santa Rosa, Calif) in
patients considered candidates for open surgical repair.
Methods: The Evaluation of the Medtronic Vascular Talent Thoracic
Stent Graft System for the Treatment of Thoracic Aortic Aneurysms
(VALOR) trial was a prospective, nonrandomized, multicenter, pivotal
study conducted at 38 sites. Between December 2003 and June 2005,
VALOR enrolled 195 patients (mean age, 70.2  11.1 years) who were at
low or moderate risk (0, 1, and 2) by the modified Society for Vascular
Surgery and American Association for Vascular Surgery criteria. The patients
had fusiform thoracic aortic aneurysms (TAA) or focal saccular TAA/
penetrating atherosclerotic ulcers, or both. Standard follow-up interval
examinations were conducted at 1 month, 6 months, 1 year, and annually
thereafter.
Results: At 5 years, freedom from aneurysm-related mortality (ARM)
was 96.1%, freedom from all-cause mortality was 58.5%, freedom from
aneurysm rupture was 97.1%, and freedom from conversion to surgery was
97.1%. ARM occurred in only one patient after the first year. Four patients
were converted to open surgery during the 5 years, 2 due to endoleak, 1 due
to aneurysm enlargement, and 1 due to perigraft infection. Four patients
experienced aneurysm rupture. From 1 month to 5 years, stent graft migra-
tion 5 mm was documented in eight patients. There were eight patients
with loss of stent graft integrity, all of which occurred after 2 years. The rate
of type I endoleak was 4.6% up to 1 month, 6.3% from 1 month to 1 year,
and 3.8% during year 5. The rate of type III endoleak was 1.3% 1 month,
1.9% from 1 month to 1 year, and 1.9% during year 5. Through 5 years, 30
patients underwent additional endovascular procedures.
Conclusion: Through 5 years of follow-up in patients who were
candidates for open surgical repair, TEVAR using the Talent Thoracic Stent
Graft System demonstrated sustained protection from ARM, aneurysm
rupture, and conversion to surgery, as well as durable stent graft perfor-
mance.
RemoteWireless Sensing for Aneurysm Sac Pressure SacMeasurements
After Thoracic Endovascular Aneurysm Repair: An Initial Experience
and a Midterm Follow-up
Muhammad Aftab, Chuo Ren Leong,MD, Ankur Chawla,MD, Xin Yun Li,
MD, Sotero Peralta, MD, Shabana Perveen, MD, Kambhampaty Krishna-
sastry, MD, Department of Surgery, North Shore Long Island Jewish
Health System, Massnhasset, NY
Objective(s): Remote wireless pressure-sensing is a modality used to
identify successful aneurysm exclusion after endovascular repair. The efficacy
and accuracy of the sensors is promising in detecting endoleak in patients
after endovascular aneurysm repair (EVAR). Little evidence exists regarding
their utility in thoracic EVAR (TEVAR). This study reported our experience
with the EndoSure® system in patients with TEVAR and its role in detecting
intraoperative and postoperative endoleak during the aneurysm surveillance.
Methods: This is a retrospective review of the prospectively collected
data on eight patients in our aortic registry who underwent TEVAR with
EndoSure® device placement.
Results:All grafts and sensors were successfully deployed. Sac pressures
were measured before and after TEVAR in the operating room and during
follow-up with intravenous contrast computed tomography (CT) scans.
Intraoperative type I endoleak was detected in two patients with the Endo-
Sure® system, which were promptly repaired using the extension cuffs. The
EndoSure® system also detected three postoperative endoleaks: two distal
type I and one retrograde leak via a revascularized superior mesenteric artery
(SMA). The endoleaks were initially identified by persistently high sac
pressure measurements and further confirmed by CT scans. Both distal type
I endoleaks were repaired by extension cuffs, and the retrograde SMA
endoleak was repaired by coil embolization of the SMA. Two of the three
endoleaks were detected in hybrid TEVAR patients. The aortic sac pulse
pressure ratio (ASPPR) in all patients decreased during surveillance, corre-
lating with the CT scan findings and demonstrating a 5 mm reduction in
aortic diameter in 75% of patients (P  .009).
Conclusions: This is one of the few studies reporting the utility of
EndoSure system in TEVAR and hybrid TEVAR patients. The EndoSure®
system provides useful information for the detection of intraoperative and
postoperative type I endoleak in TEVAR and also provides serial follow-up
data in patients with type II endoleak. We recommend using this modality
only as an adjunct to radiologic imaging in TEVAR patients. The informa-
tion provided by the EndoSure® System should be interpreted with caution.
Larger studies with a long-term follow-up and cost-analysis are required to
further define the utility of this modality in TEVAR.orse Long-term Outcomes After Endovascular Aneurysm Repair in
atients With Aortoiliac Aneurysms Involving the Iliac Bifurcation: An
pportunity for Iliac Branched Grafts?
uhammad Asad Khan, MD, Douglas W. Jones, MD, John Karwowski,
D, Harry L. Bush, MD, James F. McKinsey, MD, Darren B. Schneider,
D, New York Presbyterian/Weill Cornell Medical Center, New York, NY
Objective(s): Endovascular aneurysm repair (EVAR) has become the
tandard treatment of abdominal aortic aneurysms (AAA) and is also com-
only used for treatment of aortoiliac aneurysms. However, treatment of
ortoiliac aneurysms involving the iliac bifurcation often requires hypogas-
ric artery sacrifice during EVAR, which may result in ischemic complica-
ions and buttock claudication. We hypothesized that aneurysmal involve-
ent of the iliac arteries also has a negative effect on the durability of EVAR
nd sought to determine what fraction of these patients could be candidates
or internal iliac artery preservation with an iliac branch graft device (IBG).
Methods: A review of 632 patients who underwent EVAR at a single
nstitution between 2001 and 2010 was performed. Patients were divided
nto two groups: group 1 included patients who underwent EVAR for
reatment of aneurysms that did not involve the iliac bifurcation, and group
included patients with aortoiliac aneurysms that involved the iliac bifurca-
ion (diameter 22 mm). Operative details and outcomes were compared
etween the groups and preprocedural computed tomography (CT) scans of
atients in group 2 were used to determine if anatomy was suitable for IBG.915
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September 2011916 AbstractsResults: Of 632 patients, 586 (522 group 1, 64 group 2) had data
available for analysis with a mean follow-up of 26months. During EVAR, 60
patients (94%) in group 2 underwent coil embolization and coverage of the
internal iliac artery. In group 2 patients, the 5-year endoleak-free survival was
significantly lower (57%  10% vs 72  5%; P  .018), incidence of distal
iliac artery attachment site (type Ib) endoleak was significantly higher (0.7%
vs 7.8%, P  .001), and reintervention-free survival was significantly lower
(68%  11% vs 77  4%, P  .027). Anatomy in 42 patients (66%) was
deemed suitable for use of iliac branched grafts, and presence of a hypogas-
tric artery aneurysm was the most frequent reason restricting iliac branched
grafts candidacy.
Conclusions: Patients with aneurysms involving the iliac bifurcation
usually require internal iliac artery sacrifice during EVAR and have worse
long-term outcomes, with significantly higher rates of endoleak and reinter-
vention. The anatomy in 50% of these patients is suitable for internal iliac
preservation with an iliac branched graft, which could improve long-term
outcomes after EVAR in patients with iliac involvement.
Duplex Ultrasound Imaging to Detect Endovascular Aneurysm Repair
Limb Stenosis or Kinking After Midterm Follow-up
Aaron S. Blom, DO, MBA, Douglas Troutman, DO, Brian Beeman, MD,
Mark Yarchoan, BA, Matthew J. Dougherty, MD, Keith D. Calligaro, MD,
Pennsylvania Hospital, Philadelphia, Pa
Objective(s): We attempted to determine the utility of duplex ultra-
sound (DU) imaging in predicting endovascular aneurysm repair (EVAR)
limb stenosis or kinking.
Methods: Between 1998 and 2010, 248 patients underwent EVAR
and postoperative DU surveillance of 496 limbs in our accredited noninva-
sive vascular laboratory by one of three experienced technologists. Routine
DU surveillance was performed at 1 week, 6 months, and annually after
grafts inserted during EVAR. Peak systolic velocities (PSVs) were measured
in the mid-portion and distal anastomoses of both limbs of the graft, and
adjacent PSV ratios were calculated.
Results:None of 479 limbs with a PSV300 cm/s occluded during a
mean midterm follow-up of 22.3 months (range, 1-123 months). Of 17
limbs with a PSV 300 cm/s, 12 occluded (n  7; 0/479 vs 7/17, p 
0.01) or underwent prophylactic intervention (n  5; mean adjacent PSV
ratio  7.3), and 5 limbs remained patent without intervention (mean PSV
ratio  2.0; sensitivity  100%; specificity  95%).
Conclusions: This is the largest reported series of DU surveillance for
failing EVAR devices and suggests that limbs with PSVs 300 cm/s can be
safely monitored. However, limbs with more elevated PSVs may benefit
from prophylactic intervention ormore frequent surveillance to prevent limb
occlusion.
Chronic Kidney Disease Class Predicts Mortality After Abdominal
Aortic Aneurysm Repair in Propensity-Matched Cohorts from the
Medicare Population
Nathan J. Aranson, MD, Virendra I. Patel, MD, Emel Ergul, MS, Glenn M.
LaMuraglia, MD, Christopher J. Kwolek, MD, Richard P. Cambria, MD,
Mark F. Conrad, MD, Massachusetts General Hospital, Boston, Mass
Objective(s):Chronic renal insufficiency (CKD) is a predictor of death
after abdominal aortic aneurysm (AAA) repair. However, few studies are
adequately powered to stratify risk by CKD severity. The goal of this study
was to assess the effect of CKD severity on survival after AAA repair.
Methods: All patients who underwent open or endovascular AAA
repair from 2006 to 2007 were retrospectively identified in the Medicare
database and stratified by CKD stage into 3 groups: normal (CKD 0-1),
moderate (CKD 2-4), and severe (CKD 5-6). Propensity matching (30:1) of
known risk factors was performed. The primary outcome was death; second-
ary outcomes included hospital length of stay (LOS) and cost.
Results: We identified 47,715 patients (96.7% normal, 1.88% moder-
ate, 1.65% severe). After propensity matching, there was no difference in
comorbidities between cohorts. The 30-day mortality was significantly
higher in the moderate (5.7%) vs normal (2.5%, P  0.0001) and severe
(9.9%) vs normal (1.8%; P 0.0001) groups. The 3-year survival favored the
normal cohort (80%) vs moderate (64%; P  0.0001) and 81% vs severe
(44%; P  0.0001). Hospital LOS increased with CKD severity (4.4 days
normal vs 6.5 moderate, P  .0001; 4.7 normal vs 9.1 days severe, P 
.0001) as did cost ($77,275 normal vs $97,410 moderate, P  .0001;
$73,273 normal vs $113,863 severe, P  .0001).
Conclusions: CKD severity is an important predictor of perioperative
mortality and long-term survival after AAA repair in propensity matched
cohorts. The fivefold increase in 30-day mortality and mere 44% 3-year
survival suggest that elective AAA repair is contraindicated in most patients
with severe CKD.mproved Long-term Results Using Onyx Glue for the Treatment of
ersistent Type II Endoleak After Endovascular Aneurysm Repair
hristopher J. Abularrage, MD, Virendra I. Patel, MD, Mark F. Conrad,
D, Richard P. Cambria, MD, Christopher J. Kwolek, MD, Johns Hopkins
ospital, Baltimore, Md
Objective(s): Persistent type II (PTII) endoleaks after EVAR are the
ost common indication for reintervention; however, these reinterventions
re associated with inferior results. This study evaluated outcomes of rein-
ervention for PTII endoleak during an 8-year period.
Methods: From 1999 to 2007, PTII endoleak developed in 136 of
32 patients. Patients with other types of endoleak were excluded from
nalysis. Primary end points included PTII resolution (reinterventional
uccess), change in aneurysm sac size, and survival. End points were evalu-
ted using 2 and Kaplan-Meier analyses.
Results: Forty-nine patients underwent 65 endovascular reinterven-
ions for PTII and an expanding aneurysm sac with a median follow-up of
3.7 months (Table). Reintervention success rate was 40% (26 of 65). Onyx
lue embolization was associated with a greater success rate (76% vs 31%,
 .0005) and inferior mesenteric artery coil embolization had a lower
uccess rate (20% vs 52%, P  .03). The mean change in aneurysm sac
iameter from preintervention to the maximum follow-up was decreased
nly in the Onyx glue embolization group (–2.25  1.39 vs 2.98  0.75
m, P  .0008). Survival at 5 years was 72.3%  0.08% and was not
redicted by any of the reinterventional techniques.
Conclusions:Reintervention for PTII is associated with success in 40%
f cases. Onyx glue embolization led to increased success rates and decrease
n the aneurysm sac diameter, and therefore, should be considered as
rst-line therapy for treating PTII endoleak.
able. Endovascular reinterventions
ariable No.
Long-term success
No. (%) P
ll endovascular reinterventions 65 26 (40) .006
nyx glue 17 13 (76)
on-Onyx glue 10 2 (20)
oil embolization
Lumbar 7 3 (43)
Sac 11 4 (36)
Inferior mesenteric artery 20 4 (20)
idterm Outcome of Endovascular Popliteal Artery Aneurysm Repair
sing the Viabahn Endoprosthesis
aran Garg, Caron B. Rockman, MD, Billy J. Kim,MD, Glenn R. Jacobow-
tz, MD, Thomas S. Maldonado, MD, Patrick J. Lamparello, MD, Mark A.
delman, MD, Frank J. Veith, MD, Neal S. Cayne, MD, New York
niversity Langone Medical Center, New York, NY
Objective(s):This study reviews a single-center experience of endovas-
ular popliteal aneurysm repair with Viabahn® endoprosthesis (W.L. Gore
Associates, Inc, Flagstaff, Ariz).
Methods: A retrospective review was performed to identify all endo-
ascular popliteal artery aneurysm (PAA) repairs performed between Sep-
ember 2004 and January 2011. A total of 21 patients (91% male; mean age,
4 9 years) with PAAs (mean size 2.89 1.0 cm, 38% symptomatic) in 26
imbs were identified. All underwent endovascular repair with a Viabahn®
overed stent graft. Patient and operative characteristics are listed in the
ccompanying Table. All patients were maintained on antiplatelet therapy
ostoperatively with clopidogrel and/or aspirin.
able. Study characteristics
ariables Mean  SD, or No. (%)
atient considerations
Age, years 74  9
Male sex 19/21 (90.5)
Bilateral popliteal aneurysms 10/21 (48)
History of AAA 11/21 (52)
AAA diameter (median), cm 2.89  1.0
Percentage asymptomatic 16/26 (62)
perative considerations
Locoregional anesthesia 17/26 (65)
Technical success 25/26 (96)
